239 related articles for article (PubMed ID: 33933071)
21. Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease.
Henriques AG; Oliveira JM; Carvalho LP; da Cruz E Silva OAB
Mol Neurobiol; 2015 Dec; 52(3):1391-1407. PubMed ID: 25344315
[TBL] [Abstract][Full Text] [Related]
22. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
23. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.
Ma J; Huo X; Jarpe MB; Kavelaars A; Heijnen CJ
Acta Neuropathol Commun; 2018 Oct; 6(1):103. PubMed ID: 30270813
[TBL] [Abstract][Full Text] [Related]
25. HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila.
Xiong Y; Zhao K; Wu J; Xu Z; Jin S; Zhang YQ
Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4604-9. PubMed ID: 23487739
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
27. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in
Mao CX; Wen X; Jin S; Zhang YQ
Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043
[TBL] [Abstract][Full Text] [Related]
28. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
Liu Y; Peng L; Seto E; Huang S; Qiu Y
J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional studies of USP20 ZnF-UBP domain by NMR.
Yang Y; Ding Y; Zhou C; Wen Y; Zhang N
Protein Sci; 2019 Sep; 28(9):1606-1619. PubMed ID: 31278784
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade.
Ohkubo N; Lee YD; Morishima A; Terashima T; Kikkawa S; Tohyama M; Sakanaka M; Tanaka J; Maeda N; Vitek MP; Mitsuda N
FASEB J; 2003 Feb; 17(2):295-7. PubMed ID: 12490540
[TBL] [Abstract][Full Text] [Related]
31. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
[TBL] [Abstract][Full Text] [Related]
32. HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity.
Tsushima H; Emanuele M; Polenghi A; Esposito A; Vassalli M; Barberis A; Difato F; Chieregatti E
Nat Commun; 2015 Jul; 6():7781. PubMed ID: 26198811
[TBL] [Abstract][Full Text] [Related]
33. Dimethyl Fumarate Mitigates Tauopathy in Aβ-Induced Neuroblastoma SH-SY5Y Cells.
Rajput MS; Nirmal NP; Rathore D; Dahima R
Neurochem Res; 2020 Nov; 45(11):2641-2652. PubMed ID: 32816241
[TBL] [Abstract][Full Text] [Related]
34. Interplay between HDAC6 and its interacting partners: essential roles in the aggresome-autophagy pathway and neurodegenerative diseases.
Yan J
DNA Cell Biol; 2014 Sep; 33(9):567-80. PubMed ID: 24932665
[TBL] [Abstract][Full Text] [Related]
35. TPPU protects tau from H
Yao ES; Tang Y; Liu XH; Wang MH
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507
[TBL] [Abstract][Full Text] [Related]
36. UCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment.
Yu Q; Zhang H; Li Y; Liu C; Wang S; Liao X
Mol Neurobiol; 2018 May; 55(5):3812-3821. PubMed ID: 28540657
[TBL] [Abstract][Full Text] [Related]
37. The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation.
Ustinova K; Novakova Z; Saito M; Meleshin M; Mikesova J; Kutil Z; Baranova P; Havlinova B; Schutkowski M; Matthias P; Barinka C
J Biol Chem; 2020 Feb; 295(9):2614-2628. PubMed ID: 31953325
[TBL] [Abstract][Full Text] [Related]
38. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
[TBL] [Abstract][Full Text] [Related]
39. Structure-Based Drug Designing Recommends HDAC6 Inhibitors To Attenuate Microtubule-Associated Tau-Pathogenesis.
Zeb A; Park C; Rampogu S; Son M; Lee G; Lee KW
ACS Chem Neurosci; 2019 Mar; 10(3):1326-1335. PubMed ID: 30407786
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
